Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment

Robert E Till, Bill E. Beckwith

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

DDAVP has been shown to facilitate memory, especially retrieval, in humans. Healthy young male adult subjects received DDAVP (60 μg) in a cross-over design with a one-week interval between sessions. Results indicated that DDAVP improved immediate memory during the first but not the second testing session, particularly for low-verbal subjects. Treatment with DDAVP also facilitated delayed (one-week) recall in the opposite group, a cross-over interaction that suggests a retrieval locus for the DDAVP effect. Furthermore, since DDAVP improved immediate memory more for low-verbal subjects and delayed memory more for high-verbal subjects, it appears that individual difference factors will be important in understanding the effects of vasopressin on memory.

Original languageEnglish (US)
Pages (from-to)397-402
Number of pages6
JournalPeptides
Volume6
Issue number3
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

Deamino Arginine Vasopressin
Vasopressins
Data storage equipment
Experiments
Short-Term Memory
Repression (Psychology)
Individuality
Cross-Over Studies
Young Adult
Testing

Keywords

  • DDAVP
  • Memory
  • Neuropeptide
  • Vasopressin

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment. / Till, Robert E; Beckwith, Bill E.

In: Peptides, Vol. 6, No. 3, 1985, p. 397-402.

Research output: Contribution to journalArticle

@article{56247f76ee6e47f0abc6aa4ca81f5dbd,
title = "Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment",
abstract = "DDAVP has been shown to facilitate memory, especially retrieval, in humans. Healthy young male adult subjects received DDAVP (60 μg) in a cross-over design with a one-week interval between sessions. Results indicated that DDAVP improved immediate memory during the first but not the second testing session, particularly for low-verbal subjects. Treatment with DDAVP also facilitated delayed (one-week) recall in the opposite group, a cross-over interaction that suggests a retrieval locus for the DDAVP effect. Furthermore, since DDAVP improved immediate memory more for low-verbal subjects and delayed memory more for high-verbal subjects, it appears that individual difference factors will be important in understanding the effects of vasopressin on memory.",
keywords = "DDAVP, Memory, Neuropeptide, Vasopressin",
author = "Till, {Robert E} and Beckwith, {Bill E.}",
year = "1985",
doi = "10.1016/0196-9781(85)90103-2",
language = "English (US)",
volume = "6",
pages = "397--402",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Sentence memory affected by vasopressin analog (DDAVP) in cross-over experiment

AU - Till, Robert E

AU - Beckwith, Bill E.

PY - 1985

Y1 - 1985

N2 - DDAVP has been shown to facilitate memory, especially retrieval, in humans. Healthy young male adult subjects received DDAVP (60 μg) in a cross-over design with a one-week interval between sessions. Results indicated that DDAVP improved immediate memory during the first but not the second testing session, particularly for low-verbal subjects. Treatment with DDAVP also facilitated delayed (one-week) recall in the opposite group, a cross-over interaction that suggests a retrieval locus for the DDAVP effect. Furthermore, since DDAVP improved immediate memory more for low-verbal subjects and delayed memory more for high-verbal subjects, it appears that individual difference factors will be important in understanding the effects of vasopressin on memory.

AB - DDAVP has been shown to facilitate memory, especially retrieval, in humans. Healthy young male adult subjects received DDAVP (60 μg) in a cross-over design with a one-week interval between sessions. Results indicated that DDAVP improved immediate memory during the first but not the second testing session, particularly for low-verbal subjects. Treatment with DDAVP also facilitated delayed (one-week) recall in the opposite group, a cross-over interaction that suggests a retrieval locus for the DDAVP effect. Furthermore, since DDAVP improved immediate memory more for low-verbal subjects and delayed memory more for high-verbal subjects, it appears that individual difference factors will be important in understanding the effects of vasopressin on memory.

KW - DDAVP

KW - Memory

KW - Neuropeptide

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0022181580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022181580&partnerID=8YFLogxK

U2 - 10.1016/0196-9781(85)90103-2

DO - 10.1016/0196-9781(85)90103-2

M3 - Article

VL - 6

SP - 397

EP - 402

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 3

ER -